| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 8e-06 |